SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-058708
Filing Date
2017-11-14
Accepted
2017-11-14 10:05:40
Documents
46
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv478651_10q.htm 10-Q 245008
2 EXHIBIT 31.1 tv478651_ex31-1.htm EX-31.1 7533
3 EXHIBIT 31.2 tv478651_ex31-2.htm EX-31.2 7628
4 EXHIBIT 32.1 tv478651_ex32-1.htm EX-32.1 4166
5 EXHIBIT 32.2 tv478651_ex32-2.htm EX-32.2 4112
  Complete submission text file 0001144204-17-058708.txt   1966801

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT casi-20170930.xml EX-101.INS 306805
7 XBRL TAXONOMY EXTENSION SCHEMA casi-20170930.xsd EX-101.SCH 23502
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20170930_cal.xml EX-101.CAL 20389
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20170930_def.xml EX-101.DEF 162352
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20170930_lab.xml EX-101.LAB 185016
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20170930_pre.xml EX-101.PRE 181833
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 171198943
SIC: 2836 Biological Products, (No Diagnostic Substances)